Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

NCT05043649 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped lack of timely enrollment

Conditions

Advanced Soft-tissue Sarcoma

Interventions

DRUG: Camsirubicin

Sponsor

Monopar Therapeutics